Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients - Wikidata - awgldk - TriplyDB

Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients

Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients

http://www.wikidata.org/entity/Q37135790

about

The ANG-(1-7)/ACE2/mas axis in the regulation of nephron function The intrarenal generation of angiotensin II is required for experimental hypertension Roles of the (pro)renin receptor in the kidney Salt-Sensitive Hypertension: Perspectives on Intrarenal Mechanisms Role of the intrarenal renin-angiotensin-aldosterone system in chronic kidney disease.Association between urinary angiotensinogen levels and renal and cardiovascular prognoses in patients with type 2 diabetes mellitus.Detailed localization of augmented angiotensinogen mRNA and protein in proximal tubule segments of diabetic kidneys in rats and humans.Genetic architecture of complex traits predisposing to nephropathy: hypertension.Urinary angiotensinogen accurately reflects intrarenal Renin-Angiotensin system activity.Serum soluble (pro)renin receptor levels in patients with essential hypertension Translational studies on augmentation of intratubular renin-angiotensin system in hypertension Urinary angiotensinogen is correlated with blood pressure in men (Bogalusa Heart Study).Recent advances involving the renin-angiotensin system Nonclassical renin-angiotensin system and renal function.Urinary sodium excretion has positive correlation with activation of urinary renin angiotensin system and reactive oxygen species in hypertensive chronic kidney disease.Intrarenal angiotensin-converting enzyme induces hypertension in response to angiotensin I infusion Circadian rhythm of plasma and urinary angiotensinogen in healthy volunteers and in patients with chronic kidney disease.Intratubular renin-angiotensin system in hypertension Intrarenal angiotensin II and its contribution to the genesis of chronic hypertension.Strategies to improve detection of hypertension genes Urinary angiotensinogen reflects the activity of intrarenal renin-angiotensin system in patients with IgA nephropathy.Relationship between urinary angiotensinogen and salt sensitivity of blood pressure in patients with IgA nephropathy.Urinary Angiotensinogen as a Novel Biomarker of Intrarenal Renin-Angiotensin System in Chronic Kidney Disease.Changes in urinary angiotensinogen posttreatment in pediatric IgA nephropathy patients Angiotensinogen Expression Is Enhanced in the Progression of Glomerular Disease.Increased urinary Angiotensinogen/Creatinine (AGT/Cr) ratio may be associated with reduced renal function in autosomal dominant polycystic kidney disease patients.Reversibility of the effects of aliskiren in the renal versus systemic circulation.Interferon-γ biphasically regulates angiotensinogen expression via a JAK-STAT pathway and suppressor of cytokine signaling 1 (SOCS1) in renal proximal tubular cells.The link between the renin-angiotensin-aldosterone system and renal injury in obesity and the metabolic syndrome.Plasma Soluble (Pro)renin Receptor Reflects Renal Damage Increased urinary excretion of angiotensinogen is associated with risk of chronic kidney disease Sexual dimorphism in urinary angiotensinogen excretion during chronic angiotensin II-salt hypertension.Role of stimulated intrarenal angiotensinogen in hypertension.Circulating and intrarenal renin-angiotensin systems in healthy men and nonpregnant women Role of H(2)O(2) in hypertension, renin-angiotensin system activation and renal medullary disfunction caused by angiotensin II.Increased urinary angiotensinogen precedes the onset of albuminuria in normotensive type 2 diabetic patients.Urinary Angiotensinogen as a Potential Biomarker of Intrarenal Renin-angiotensin System Activity in Chinese Patients with Chronic Kidney Disease.Important aspects of urine sampling for angiotensinogen measurement: time and preservation conditions in healthy individuals Augmented intrarenal and urinary angiotensinogen in hypertension and chronic kidney disease.Cardinal role of the intrarenal renin-angiotensin system in the pathogenesis of diabetic nephropathy.

P2860

Q24633556-BBA6990F-F97D-4447-8FEC-252CDA3EED9C Q27025017-32F3C29F-4747-497E-A959-4250C8FFAC0C Q27026784-672FDA34-8FFC-4F49-B9BC-251E8BBB90C9 Q28080916-0C29EF1F-E7BE-48BD-A0E6-099DE282C6E4 Q30429844-1A96F24A-5056-49FC-83ED-02FC28DBFB57 Q33585798-5007661F-2C98-472E-9869-ABF13CBA6F73 Q33716378-29D5D762-32D5-4D61-9A2E-41955C56FA53 Q33767332-2B007FD2-336F-4022-8D52-2D1AFABB76AC Q33808763-1D697D95-2701-44A9-8601-D05888C2725C Q33864665-8143DD07-2771-4662-8468-B5A7C215C04D Q33873530-46C04C56-A548-4CA7-BB2F-88B88616EC33 Q33940516-552FB1F3-DC4D-418E-99B4-A769C840E517 Q34260674-C876A0D0-1BFB-439C-AEC7-3D6576E51839 Q34293723-D9174C34-2632-43AA-A0F8-564B6747F2EE Q34325372-18F9E4EC-1F91-4769-A20E-CBA4DCBC6592 Q34695342-A06B5C2F-2117-4A64-A2AA-19796F131DA7 Q34715015-04802B10-09A5-4B01-9592-19854E7B569B Q34777649-35882515-E900-4340-A0B3-08F8722889AF Q34785905-50180D0C-FD47-4674-A1AE-F29520FC209C Q34898648-657A4D94-49A9-4544-BCBF-FEF6E464524A Q35025450-34F2180E-1B4E-44B6-AD6E-81F5433C0F29 Q35179398-1811BB53-142F-47E2-B341-E46D41CE4D0B Q35245800-AA09D281-FFB7-4FDC-B073-2BCA61E0E5E8 Q35528122-CDBA739E-3725-4DB7-93A9-D12DAED509C2 Q35663915-46376D2B-1F19-430A-9199-F6867B9A51B1 Q35669323-0929DD2D-4953-4D00-885C-4B34DB65FA8E Q35758528-1D80ECC6-3F62-4C2F-9A30-47A19D961C5C Q35913007-A0646F70-DB97-42D0-BAC0-5C6B7695061E Q35916243-0A5748C2-A2BC-475B-B379-E7443B617A65 Q36030615-8B75375E-B446-487B-85FF-FBB311A600F3 Q36129853-DAC7E3AF-218F-4071-8AB9-5BF4B6D39299 Q36166426-019EECDC-EAA3-49AE-844B-E2D5B63CE071 Q36219052-33A39A53-474C-4207-92D5-C22D41E8EC12 Q36247968-92D5AF2E-7B59-4704-B720-6567D3CDFE26 Q36252796-23FA8C06-429D-44C9-86CA-AB8A75A289BF Q36261862-6F95C9D1-ACD8-43EC-A298-0A130CFB9E04 Q36306448-12C6B3B6-0B77-4001-80DA-37235819A422 Q36421164-59D8094C-2227-4D40-8662-041660E4EF0B Q36449123-CBF50B9C-2B8D-4272-80A5-FF9B22307F39 Q36561841-C6EAFFEE-4E43-4869-BDA3-190A98855A43

P2860

Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients

http://www.wikidata.org/entity/Q37135790

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 15 December 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Urinary angiotensinogen as a n ...... tatus in hypertensive patients

@en

Urinary angiotensinogen as a n ...... atus in hypertensive patients.

@nl

type

label

Urinary angiotensinogen as a n ...... tatus in hypertensive patients

@en

Urinary angiotensinogen as a n ...... atus in hypertensive patients.

@nl

prefLabel

Urinary angiotensinogen as a n ...... tatus in hypertensive patients

@en

Urinary angiotensinogen as a n ...... atus in hypertensive patients.

@nl

P1433

Q37135790-8E34E396-83C9-4747-A2D1-309AA43FCCAA

P1476

Q37135790-36D5D45E-861B-42BE-8160-2B2C8B8EB6B7

P2093

Q37135790-1B7152DC-C53D-4111-974D-B665DAACC19C

Q37135790-216EAEFA-4368-4D1E-800D-E520454C38B8

Q37135790-61584C18-5104-4AFD-AF33-E6AE8600E7C2

Q37135790-82265907-F477-4A23-9D90-2CF98E23FD36

Q37135790-882E3093-5312-45F8-BC50-159372D4520C

Q37135790-94182D01-5875-44D9-BABF-319354F78C65

Q37135790-965450CE-64F3-4D48-889D-43CB504191D8

Q37135790-AD05AC34-44E2-4E75-9FFF-E16C0FD89275

Q37135790-ADACB0D1-C65F-435D-827A-A0C6056DFD2A

Q37135790-ECF0D0BC-2A80-4969-97D8-496022102183

P2860

Q37135790-0B5B952D-672B-4A94-B210-740D55D2F75E

Q37135790-0FE74E65-163F-4B54-9412-A4923F9EAE75

Q37135790-153486DD-D7B5-428C-98DB-F4CBCE7DAB42

Q37135790-2906A42B-20C1-474F-9B02-FDCEEB3D04CB

Q37135790-294F8E76-77EB-4AFD-9AE1-D61BDC0CAF6D

Q37135790-29DA978B-10B9-4D94-8E59-878160DA646B

Q37135790-33E175DA-D0C6-4010-9652-B32D0A3A7100

Q37135790-3A639E43-40BA-4787-88BF-9FB9521C5E07

Q37135790-4C91ED34-3469-4059-B7EE-B2D30A9055D3

Q37135790-530C76CB-C009-4884-9FBA-1D7CA19BC165

P304

Q37135790-02FDA9D4-961E-4C56-A8F2-E012D84971A3

P31

Q37135790-4C815EFE-CC47-4741-BE55-A0769364DD02

P356

Q37135790-DB48AC1A-6580-4486-8906-74752C354210

P407

Q37135790-5D0CF72D-F6BA-40B6-994D-FBE1AA559E4B

P433

Q37135790-15F67136-5BB1-4442-8FD6-526D5AB8B580

P478

Q37135790-8DD2E872-711E-4E29-856D-FC76C981C70E

P50

Q37135790-8495270A-A693-46BF-9F61-CA8C564223D9

P577

Q37135790-CE28AC86-3B87-4ADE-98F0-687FD1BDA668

P698

Q37135790-A4D35996-8CD5-4288-8CCA-AB02DD5CA5FA

P921

Q37135790-8D61172A-1C86-4593-91C0-8F66569D1CE9

Q37135790-C8893E28-4362-43F9-80E4-0BDD2EDB8BCC

P932

Q37135790-6A18F4B9-5F30-45E8-A34D-81E123A0B97A

P356

HYPERTENSIONAHA.108.123802

P1433

P1476

Urinary angiotensinogen as a n ...... tatus in hypertensive patients

@en

P2093

A Brent Alper

http://www.w3.org/2001/XMLSchema#string

Akemi Katsurada

http://www.w3.org/2001/XMLSchema#string

Kayoko Miyata

http://www.w3.org/2001/XMLSchema#string

L Gabriel Navar

http://www.w3.org/2001/XMLSchema#string

L Lee Hamm

http://www.w3.org/2001/XMLSchema#string

Maki Urushihara

http://www.w3.org/2001/XMLSchema#string

Naro Ohashi

http://www.w3.org/2001/XMLSchema#string

Rajesh Shenava

http://www.w3.org/2001/XMLSchema#string

Ryousuke Satou

http://www.w3.org/2001/XMLSchema#string

Toshie Saito

http://www.w3.org/2001/XMLSchema#string

P2860

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

Kinetics of the human renin and human substrate reaction

Blood pressure, stroke, and coronary heart disease

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Renin expression in renal proximal tubule.

The cardiac renin-angiotensin system: conceptual, or a regulator of cardiac function?

High blood pressure in transgenic mice carrying the rat angiotensinogen gene.

Role of angiotensin II in diabetic nephropathy.

Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

In situ hybridization evidence for angiotensinogen messenger RNA in the rat proximal tubule. An hypothesis for the intrarenal renin angiotensin system

P304

344-350

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/HYPERTENSIONAHA.108.123802

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

53

http://www.w3.org/2001/XMLSchema#string

P50

Hiroyuki Kobori

P577

2008-12-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19075095

http://www.w3.org/2001/XMLSchema#string

P921

P932

2658771

http://www.w3.org/2001/XMLSchema#string